Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,597 (5,100, 8,300)","50.2% (34.0%, 59.6%)","74.8% (57.1%, 86.8%)","17.1% (11.3%, 25.9%)","95.3% (92.2%, 96.7%)","12.5 (8.5, 14.9)","18.7 (14.3, 21.7)","4.3 (2.8, 6.5)","23.8 (23.1, 24.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","6,814 (5,235, 8,525)","60.7% (42.0%, 79.4%)","70.9% (52.6%, 83.6%)","15.6% (10.1%, 22.8%)","96.5% (94.1%, 97.8%)","15.2 (10.5, 19.9)","17.7 (13.2, 20.9)","3.9 (2.5, 5.7)","24.1 (23.5, 24.4)","3.3% (0.5%, 7.4%)","21.4% (6.9%, 43.8%)","-5.4% (-9.8%, -3.1%)","-8.9% (-15.5%, -4.0%)","1.3% (-1.4%, 4.0%)"
"(p=None, None), q=(None, None), c=0.750)","6,974 (5,310, 8,711)","62.7% (43.7%, 79.5%)","69.6% (52.4%, 83.2%)","15.1% (9.7%, 21.9%)","96.5% (94.3%, 98.1%)","15.7 (10.9, 19.9)","17.4 (13.1, 20.8)","3.8 (2.4, 5.5)","24.1 (23.6, 24.5)","5.8% (2.1%, 11.0%)","25.6% (7.6%, 45.7%)","-7.0% (-11.6%, -3.5%)","-12.1% (-20.1%, -5.9%)","1.3% (-0.7%, 4.0%)"
"(p=None, None), q=(None, None), c=1.000)","7,136 (5,400, 8,890)","63.0% (43.7%, 79.5%)","68.6% (51.0%, 81.7%)","14.5% (9.3%, 20.9%)","96.4% (94.0%, 98.0%)","15.7 (10.9, 19.9)","17.1 (12.7, 20.4)","3.6 (2.3, 5.2)","24.1 (23.5, 24.5)","8.3% (3.5%, 15.4%)","26.2% (7.4%, 56.1%)","-8.5% (-15.1%, -4.5%)","-15.2% (-24.2%, -7.2%)","1.2% (-1.0%, 3.7%)"
